{"id":"treatment-taken","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Pneumonitis"},{"rate":"1-5%","effect":"Hypothyroidism"},{"rate":"<1%","effect":"Hyperthyroidism"},{"rate":"<1%","effect":"Diarrhea"},{"rate":"<1%","effect":"Fatigue"},{"rate":"<1%","effect":"Nausea"},{"rate":"<1%","effect":"Vomiting"},{"rate":"<1%","effect":"Abdominal pain"},{"rate":"<1%","effect":"Muscle weakness"},{"rate":"<1%","effect":"Arthralgia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking the PD-1 receptor, the drug allows the immune system to recognize and attack cancer cells more effectively, leading to an anti-tumor response. This mechanism of action is based on the principle of immune checkpoint inhibition, which has been shown to be effective in treating various types of cancer.","oneSentence":"This drug works by inhibiting the PD-1 receptor, which plays a key role in the immune system's ability to recognize and attack cancer cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:54:27.493Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer, PD-L1 positive"},{"name":"Head and neck squamous cell carcinoma"},{"name":"Melanoma"},{"name":"Renal cell carcinoma"},{"name":"Urothelial carcinoma"}]},"trialDetails":[{"nctId":"NCT07348120","phase":"NA","title":"Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2025-05-01","conditions":"Telogen Effluvium","enrollment":60},{"nctId":"NCT07495176","phase":"NA","title":"USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias","status":"COMPLETED","sponsor":"Shanghai Children's Hospital","startDate":"2021-02-01","conditions":"Hypospadias","enrollment":82},{"nctId":"NCT03741023","phase":"NA","title":"Disorders of the Acute Phase Response Following Trauma and Invasive Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2019-12-12","conditions":"Acute Phase Response","enrollment":320},{"nctId":"NCT06617182","phase":"PHASE2","title":"Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.","status":"RECRUITING","sponsor":"Yongquan Shi","startDate":"2024-09-30","conditions":"Radiation Enteritis","enrollment":150},{"nctId":"NCT06824467","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-04-09","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer","enrollment":770},{"nctId":"NCT07305961","phase":"","title":"National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies","status":"COMPLETED","sponsor":"Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse","startDate":"2025-01-07","conditions":"Scabies","enrollment":1332},{"nctId":"NCT06623461","phase":"PHASE2","title":"LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2025-04-07","conditions":"Melanoma","enrollment":128},{"nctId":"NCT06757764","phase":"PHASE4","title":"The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-07-10","conditions":"Cerebral Infarction, Stenosis Artery","enrollment":2340},{"nctId":"NCT05521776","phase":"NA","title":"Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-06","conditions":"Preeclampsia (PE)","enrollment":14500},{"nctId":"NCT04223791","phase":"PHASE3","title":"Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-18","conditions":"HIV Infection","enrollment":643},{"nctId":"NCT05630781","phase":"NA","title":"Orexin s Role in the Neurobiology of Substance Use Disorder","status":"RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2023-02-15","conditions":"Nicotine Dependence","enrollment":140},{"nctId":"NCT03297606","phase":"PHASE2","title":"Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2018-03-23","conditions":"Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors","enrollment":720},{"nctId":"NCT06876142","phase":"PHASE1, PHASE2","title":"Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma","status":"SUSPENDED","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-01","conditions":"Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma (RRMM)","enrollment":54},{"nctId":"NCT03783000","phase":"PHASE1","title":"A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2019-01-15","conditions":"Healthy","enrollment":6},{"nctId":"NCT04633252","phase":"PHASE1, PHASE2","title":"A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-02-23","conditions":"Cancer Of Prostate, Prostate Neoplasms","enrollment":86},{"nctId":"NCT07074756","phase":"NA","title":"A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-09-12","conditions":"Glioma, Recurrent Glioma","enrollment":120},{"nctId":"NCT05012033","phase":"","title":"Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2023-04-12","conditions":"Thyroid Eye Disease, Vasculitis, COPD Exacerbation Acute","enrollment":120},{"nctId":"NCT04599478","phase":"PHASE2, PHASE3","title":"Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2021-06-29","conditions":"Loss-of-control Eating, Obesity/Overweight","enrollment":160},{"nctId":"NCT05531786","phase":"PHASE1, PHASE2","title":"Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-03-06","conditions":"Graft vs Host Disease","enrollment":50},{"nctId":"NCT03654170","phase":"PHASE1","title":"A Study in Healthy Men to Find Out How BI 425809 is Taken up and Handled by the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2018-09-11","conditions":"Healthy","enrollment":6},{"nctId":"NCT05982522","phase":"PHASE1, PHASE2","title":"IN10018 Combination Therapy in Previously-treated Solid Tumors","status":"WITHDRAWN","sponsor":"InxMed (Shanghai) Co., Ltd.","startDate":"2025-08-13","conditions":"Solid Tumor","enrollment":""},{"nctId":"NCT05210374","phase":"PHASE1","title":"Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2023-03-09","conditions":"Relapsed Sarcomas","enrollment":24},{"nctId":"NCT00931463","phase":"PHASE4","title":"A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen","status":"COMPLETED","sponsor":"Kirby Institute","startDate":"2009-09","conditions":"HIV Infections","enrollment":558},{"nctId":"NCT07225504","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-11-11","conditions":"Secondary Progressive Multiple Sclerosis (SPMS)","enrollment":1275},{"nctId":"NCT05960773","phase":"PHASE2","title":"Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma","status":"SUSPENDED","sponsor":"National Cancer Institute (NCI)","startDate":"2024-01-31","conditions":"Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma","enrollment":9},{"nctId":"NCT04645602","phase":"EARLY_PHASE1","title":"Merck IIT: RRP Pembro and Lenvatinib","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-07-18","conditions":"Human Papilloma Virus, Recurrent Respiratory Papillomatosis, Pulmonary Disease","enrollment":20},{"nctId":"NCT07493668","phase":"PHASE2","title":"Fostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After First-line Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"CHA University","startDate":"2026-04-27","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":80},{"nctId":"NCT04930744","phase":"PHASE2","title":"Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-08-26","conditions":"Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection","enrollment":112},{"nctId":"NCT06166836","phase":"PHASE1, PHASE2","title":"a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"InxMed (Shanghai) Co., Ltd.","startDate":"2022-10-12","conditions":"Solid Tumor","enrollment":140},{"nctId":"NCT04801849","phase":"PHASE2","title":"Vitamin E Dosing Study","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-08-05","conditions":"Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis","enrollment":200},{"nctId":"NCT06252649","phase":"PHASE3","title":"Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation","status":"RECRUITING","sponsor":"Amgen","startDate":"2024-07-17","conditions":"Metastatic Colorectal Cancer","enrollment":450},{"nctId":"NCT07250048","phase":"PHASE1","title":"A Study in Healthy Men to Find Out How Different Doses of BI 3009947 Are Tolerated and How Different Formulations or Food Influence How BI 3009947 is Taken up Into the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2025-11-21","conditions":"Healthy","enrollment":40},{"nctId":"NCT01783587","phase":"PHASE1","title":"Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2013-02","conditions":"Squamous Cell Carcinoma of the Head and Neck","enrollment":29},{"nctId":"NCT07492017","phase":"NA","title":"The Effect of Puzzles on Nursing Students' Learning to Intramuscular Injection: A Randomized Controlled Study","status":"COMPLETED","sponsor":"Trakya University","startDate":"2025-02-09","conditions":"Learning Concepts and Skills","enrollment":140},{"nctId":"NCT07123090","phase":"PHASE2","title":"A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma","status":"RECRUITING","sponsor":"Stephanie Berg","startDate":"2025-11-24","conditions":"Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer, Renal Cell Carcinoma","enrollment":25},{"nctId":"NCT06313437","phase":"PHASE1","title":"Revumenib in Combination With 7+3 + Midostaurin in AML","status":"RECRUITING","sponsor":"Richard Stone, MD","startDate":"2024-12-06","conditions":"Acute Myeloid Leukemia, AML, Adult, AML With Gene Mutations","enrollment":22},{"nctId":"NCT07094542","phase":"PHASE2","title":"Jaw Muscle Pain Post Wisdom Molar Surgery","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-05","conditions":"Post Operative Pain, Impacted Third Molar Tooth, Muscle Pain","enrollment":80},{"nctId":"NCT02789605","phase":"PHASE2","title":"Effectiveness and Safety of Lactobacillus Rhamnosus Lcr35® in the Treatment of Recurrent Aphthous Stomatitis","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2018-01-04","conditions":"Aphthous Stomatitis","enrollment":20},{"nctId":"NCT06765109","phase":"PHASE3","title":"Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC","status":"RECRUITING","sponsor":"Nuvalent Inc.","startDate":"2025-07-17","conditions":"Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive","enrollment":450},{"nctId":"NCT06538623","phase":"PHASE2","title":"Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer","status":"COMPLETED","sponsor":"Ruijin Hospital","startDate":"2024-08-23","conditions":"Pancreatic Neoplasms, Neoplasm Metastasis, Hepatic Metastasis of Pancreatic Cancer","enrollment":40},{"nctId":"NCT03617679","phase":"PHASE2","title":"Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2019-03-06","conditions":"Metastatic Endometrial Cancer","enrollment":79},{"nctId":"NCT07095465","phase":"PHASE3","title":"Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis","status":"ENROLLING_BY_INVITATION","sponsor":"ACADIA Pharmaceuticals Inc.","startDate":"2025-11-14","conditions":"Lewy Body Dementia Psychosis","enrollment":126},{"nctId":"NCT05888493","phase":"PHASE3","title":"A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-10-02","conditions":"Follicular Lymphoma (FL)","enrollment":109},{"nctId":"NCT07462390","phase":"NA","title":"Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Levels, Development of Complications, and Hospital Readmission in Transrectal Ultrasound-Guided Prostate Biopsy","status":"WITHDRAWN","sponsor":"Tarsus University","startDate":"2026-03-03","conditions":"TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY","enrollment":""},{"nctId":"NCT06425159","phase":"PHASE2, PHASE3","title":"A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures","status":"TERMINATED","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2024-06-20","conditions":"Generalized Epilepsy","enrollment":27},{"nctId":"NCT06998121","phase":"NA","title":"The Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Level, Complication Development in Transrectal Ultrasonography Guided Prostate Biopsy","status":"RECRUITING","sponsor":"Mersin University","startDate":"2025-06-01","conditions":"Prostate Cancer","enrollment":84},{"nctId":"NCT04712552","phase":"","title":"In Vivo Measurement of the Accuracy of the \"Neurolocate\" Module of the Neurosurgical Robot \"Neuromate\" in Its Application to Deep Brain Stimulation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2021-01-26","conditions":"Parkinson Disease, Dystonia, Tremor","enrollment":18},{"nctId":"NCT07126158","phase":"PHASE2","title":"Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-04-30","conditions":"Pancreatic Adenocarcinoma, Cancer of the Pancreas, Pancreas Cancer","enrollment":36},{"nctId":"NCT07490353","phase":"PHASE1","title":"Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2025-11-01","conditions":"Depression - Major Depressive Disorder, Anhedonia","enrollment":85},{"nctId":"NCT07491393","phase":"PHASE4","title":"Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2026-04-01","conditions":"Acute Rheumatic Pain","enrollment":24},{"nctId":"NCT07490054","phase":"PHASE1","title":"Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Melana Yuzefpolskaya, MD","startDate":"2025-09-01","conditions":"Chronic Heart Failure","enrollment":40},{"nctId":"NCT07479979","phase":"PHASE1, PHASE2","title":"Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma","status":"NOT_YET_RECRUITING","sponsor":"Natalie Callander","startDate":"2026-07","conditions":"Relapse Multiple Myeloma, Refractory Multiple Myeloma","enrollment":62},{"nctId":"NCT03887182","phase":"NA","title":"Contribution of Functional MRI in Assessment of Auditory Processing Disorders","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-09-02","conditions":"Auditory Processing Disorders","enrollment":45},{"nctId":"NCT05143840","phase":"PHASE2","title":"Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase","status":"RECRUITING","sponsor":"Augusta University","startDate":"2022-04-22","conditions":"Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid","enrollment":100},{"nctId":"NCT05212272","phase":"NA","title":"MRI in High-Grade Glioma Patients Undergoing Chemoradiation","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-09-02","conditions":"High Grade Glioma","enrollment":16},{"nctId":"NCT07236190","phase":"PHASE1, PHASE2","title":"Biomarker-based Trial of NPC-1 for Alzheimer's Pathology","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03","conditions":"Alzheimer Disease, Mild Cognitive Impairment (MCI), Subjective Cognitive Complaints (SCCs)","enrollment":40},{"nctId":"NCT07488533","phase":"PHASE2","title":"Comparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-08-01","conditions":"Non-Clear Cell Renal Cell Carcinoma","enrollment":40},{"nctId":"NCT05467891","phase":"PHASE2","title":"Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer","status":"RECRUITING","sponsor":"Oana Danciu","startDate":"2022-09-13","conditions":"Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer","enrollment":200},{"nctId":"NCT05500326","phase":"PHASE2","title":"Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Murdoch Childrens Research Institute","startDate":"2025-06-24","conditions":"Scabies; Itch, Scabies","enrollment":120},{"nctId":"NCT05099770","phase":"PHASE3","title":"Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease","status":"RECRUITING","sponsor":"Prokidney","startDate":"2022-01-05","conditions":"Type 2 Diabetes Mellitus, Chronic Kidney Diseases","enrollment":685},{"nctId":"NCT04998669","phase":"PHASE2","title":"Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma","status":"RECRUITING","sponsor":"Juan P. Alderuccio, MD","startDate":"2022-02-11","conditions":"Follicular Lymphoma","enrollment":100},{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT06897579","phase":"PHASE2","title":"Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2025-04-07","conditions":"Extensive Stage Small Cell Lung Cancer","enrollment":134},{"nctId":"NCT06860542","phase":"PHASE2","title":"Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2026-02-10","conditions":"Pneumonitis, Immune-related Adverse Event","enrollment":94},{"nctId":"NCT07062614","phase":"","title":"Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a Diagnostic Tool for Partial and/or Total Non-compliance With Treatment","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-07-03","conditions":"HIV (Human Immunodeficiency Virus)","enrollment":30},{"nctId":"NCT07393360","phase":"NA","title":"Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment","status":"RECRUITING","sponsor":"Pharmanutra S.p.a.","startDate":"2025-12-11","conditions":"Obesity & Overweight","enrollment":144},{"nctId":"NCT05364008","phase":"PHASE3","title":"FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2023-01-05","conditions":"Leiomyoma, Uterine","enrollment":33},{"nctId":"NCT04742634","phase":"PHASE1, PHASE2","title":"Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2022-05-12","conditions":"Myelodysplastic Syndromes","enrollment":209},{"nctId":"NCT06690151","phase":"","title":"Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2025-02-28","conditions":"Heart Disease Congenital, Neurodevelopmental Disorder","enrollment":450},{"nctId":"NCT07486453","phase":"PHASE1","title":"Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2026-03-09","conditions":"Primary Hypertension","enrollment":60},{"nctId":"NCT05595577","phase":"NA","title":"Improving Exercise Capacity With a Tailored Physical Activity Intervention","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-03-01","conditions":"Non Hodgkin Lymphoma, Heart; Functional Disturbance, Hodgkin Lymphoma","enrollment":110},{"nctId":"NCT07326709","phase":"PHASE3","title":"A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-06-01","conditions":"Huntington Disease","enrollment":770},{"nctId":"NCT07484217","phase":"PHASE3","title":"Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol","status":"RECRUITING","sponsor":"Axsome Therapeutics, Inc.","startDate":"2026-02-23","conditions":"Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms","enrollment":508},{"nctId":"NCT05421858","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2024-12-11","conditions":"Candidemia, Candidiasis, Invasive","enrollment":450},{"nctId":"NCT07398404","phase":"PHASE1, PHASE2","title":"A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2026-07-01","conditions":"Obesity, Smoking Cessation, Bariatric Surgery Patients","enrollment":64},{"nctId":"NCT07486011","phase":"NA","title":"Effects of Osteopathic Treatment in Patients With Somatosensory Tinnitus","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2022-09-02","conditions":"Tinnitus","enrollment":54},{"nctId":"NCT05268289","phase":"PHASE2","title":"Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-08-10","conditions":"Lupus Nephritis","enrollment":240},{"nctId":"NCT04576455","phase":"PHASE2","title":"A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2020-11-27","conditions":"Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer","enrollment":303},{"nctId":"NCT04191096","phase":"PHASE3","title":"Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-12","conditions":"Metastatic Hormone-Sensitive Prostate Cancer","enrollment":1251},{"nctId":"NCT06440135","phase":"PHASE1","title":"Ziftomenib Maintenance Post Allo-HCT","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-06-11","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, NPM1 Mutation","enrollment":22},{"nctId":"NCT05602246","phase":"NA","title":"Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS","status":"RECRUITING","sponsor":"Charles University, Czech Republic","startDate":"2022-12-01","conditions":"Pelvic Organ Prolapse, Cystocele, Cystocele and Incomplete Uterovaginal Prolapse","enrollment":592},{"nctId":"NCT03958747","phase":"NA","title":"Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-12-17","conditions":"Gastrointestinal Cancer, Colorectal Cancer","enrollment":20},{"nctId":"NCT07482059","phase":"PHASE1, PHASE2","title":"A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2026-02","conditions":"Unresectable Hepatocellular Carcinoma","enrollment":33},{"nctId":"NCT06246643","phase":"PHASE2","title":"A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2024-01-24","conditions":"Solid Malignant Tumors","enrollment":13},{"nctId":"NCT07483229","phase":"NA","title":"A Clinical Study on Warm Needling Moxibustion at Tianshu and Guanyuan Acupoints","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Henan University of Traditional Chinese Medicine","startDate":"2022-08-01","conditions":"Constipation - Functional","enrollment":60},{"nctId":"NCT05480228","phase":"PHASE2","title":"EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA","status":"COMPLETED","sponsor":"James P. Rathmell, MD","startDate":"2022-09-21","conditions":"Painful Diabetic Neuropathy","enrollment":127},{"nctId":"NCT05348733","phase":"","title":"A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2022-06-13","conditions":"Chronic Kidney Disease, Type 2 Diabetes Mellitus","enrollment":4500},{"nctId":"NCT06994715","phase":"NA","title":"Effects of Acupressure Applied to Intensive Care Patients on Physiological Parameters, Pain, Sleep Quality, Anxiety and Perception of Nursing Presence","status":"COMPLETED","sponsor":"Gazi University","startDate":"2025-05-01","conditions":"Acupressure, Intensive Care Unit, Anxiety","enrollment":60},{"nctId":"NCT07224087","phase":"PHASE1","title":"Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-03-02","conditions":"Obesity, Smoking Cessation, Bariatric Surgery Patients","enrollment":20},{"nctId":"NCT07220083","phase":"PHASE3","title":"A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)","status":"RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2026-02-16","conditions":"Focal Segmental Glomerulosclerosis","enrollment":286},{"nctId":"NCT05799105","phase":"PHASE4","title":"OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers","status":"RECRUITING","sponsor":"Stephen Firkins","startDate":"2023-03-14","conditions":"Marginal Ulcer","enrollment":122},{"nctId":"NCT07482592","phase":"PHASE1","title":"Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors","status":"NOT_YET_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2026-03","conditions":"Advanced Malignant Cancer","enrollment":156},{"nctId":"NCT06678685","phase":"PHASE2, PHASE3","title":"Spironolactone Improved Children With Gene Mutations Related to NCOR","status":"COMPLETED","sponsor":"Qilu Hospital of Shandong University","startDate":"2024-10-30","conditions":"NCOR Gene Mutations, Spironolactone, ASD","enrollment":2},{"nctId":"NCT05348876","phase":"PHASE4","title":"A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)","status":"RECRUITING","sponsor":"Bayer","startDate":"2022-08-03","conditions":"Non-metastatic Castration-resistant Prostate Cancer","enrollment":50},{"nctId":"NCT05529927","phase":"PHASE2","title":"Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Parnassia Addiction Research Centre","startDate":"2026-05","conditions":"Cocaine Use Disorder","enrollment":204},{"nctId":"NCT04253964","phase":"PHASE2","title":"Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2020-07-01","conditions":"Nonsmall Cell Lung Cancer, Performance Status","enrollment":105},{"nctId":"NCT05318196","phase":"","title":"Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2022-09-05","conditions":"Acute Kidney Injury, Chronic Kidney Diseases, Solid-organ Transplantation","enrollment":5000},{"nctId":"NCT06782464","phase":"NA","title":"Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment","status":"RECRUITING","sponsor":"Centre National de Rééducation Fonctionnelle et de Réadaptation","startDate":"2024-12-12","conditions":"Hemiplegia, Spasticity, Shoulder Spasticity","enrollment":50},{"nctId":"NCT05119270","phase":"NA","title":"Comparison of Phacoemulsification and Corneal Damage Between FLACS and Standard Phaco With Two Handpieces","status":"WITHDRAWN","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2021-12-01","conditions":"Corneal Endothelial Cell Loss, Cataract, Astigmatism","enrollment":""},{"nctId":"NCT07294729","phase":"NA","title":"Mulligan and Proprioceptive Neuromuscular Facilitation Techniques in Individuals With Rotator Cuff Lesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medipol University","startDate":"2025-12-25","conditions":"Rotator Cuff Syndrome, Rotator Cuff Injuries","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Treatment taken","genericName":"Treatment taken","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug works by inhibiting the PD-1 receptor, which plays a key role in the immune system's ability to recognize and attack cancer cells. Used for Non-small cell lung cancer, PD-L1 positive, Head and neck squamous cell carcinoma, Melanoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}